Pliant Therapeutics, Inc.

NASDAQ:PLRX

1.63 (USD) • At close June 6, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q1
Omzet 000004.8400.2481.3321.9651.4824.9891.2491.9991.611.7892.1744.4654.8143.628.93857.0520000
Kosten van de omzet 0000.6220.5130.4641.0451.1041.0611.0531.030.8990.6992.0870.400000000000
Brutowinst 000-0.622-0.5134.376-1.045-0.8560.2710.9120.4524.090.55-0.0881.211.7892.1744.4654.8143.628.93857.0520000
Brutowinstmarge 000000.9040-3.4520.2030.4640.3050.820.44-0.0440.75211111110000
Onderzoek- en ontwikkelingskosten 43.43638.79347.75444.99536.63332.71932.33933.00229.27325.11424.60626.33520.88118.75221.05219.21818.52717.85416.88417.53613.91911.72710.77913.09811.7495.018
Algemene en administratieve kosten 15.49914.52714.2615.02215.24613.85415.34614.57414.15414.2518.8238.2968.5797.8467.6715.4756.5665.6274.5913.044.0113.1032.5832.6432.6011.21
Verkoop- en marketingkosten 00000000000000000000000000
Verkoop-, algemene en administratieve kosten 15.49914.52714.2615.02215.24613.85415.34614.57414.15414.2518.8238.2968.5797.8467.6715.4756.5665.6274.5913.044.0113.1032.5832.6432.6011.21
Overige kosten 00000000000000000-0.0970.055-0.136-0.188-0.168-0.041-0.0210.0140
Bedrijfskosten 58.93553.3262.01460.01751.87946.57347.68547.57643.42739.36533.42934.63129.4626.59828.72324.69325.09323.48121.47520.57617.9314.8313.36215.74114.356.238
Bedrijfsresultaat -58.935-53.32-62.014-60.639-52.392-47.037-47.685-47.328-42.095-37.4-31.947-29.642-28.211-24.599-27.113-22.904-22.919-19.016-16.661-16.97611.00842.222-13.362-15.741-14.35-6.228
Bedrijfsresultaat ratio 00000-9.7180-190.839-31.603-19.033-21.557-5.941-22.587-12.306-16.84-12.803-10.542-4.259-3.461-4.7160.380.740000
Totaal overige inkomsten en kosten netto 2.7693.5884.2514.7855.4375.9286.1986.1364.5472.341.3320.0960.1110.0680.0680.0730.063-0.0110.127-0.0250.021-0.0530.1070.2190.3270.006
Inkomen voor belasting -56.166-49.732-57.763-55.854-46.955-41.109-41.487-41.192-37.548-35.06-30.615-29.546-28.1-24.531-27.045-22.831-22.856-19.027-16.534-17.00111.02942.169-13.255-15.522-14.023-6.222
Inkomen voor belasting ratio 00000-8.4940-166.097-28.189-17.842-20.658-5.922-22.498-12.272-16.798-12.762-10.513-4.261-3.435-4.7230.3810.7390000
Belastingkosten 00000.473.398-0.4486.455-9.405-0.455-2.6640.269-0.2220.272-0.012-0.030-0.433-0.402-0.111-0.209-0.115-0.148-0.24-0.3130.882
Nettowinst -56.166-49.732-57.763-55.854-46.955-41.109-41.487-41.192-28.143-34.605-27.951-29.546-27.878-24.531-27.045-22.831-22.856-19.027-16.534-17.00111.02940.022-13.255-15.522-14.023-7.104
Nettowinstmarge 00000-8.4940-166.097-21.128-17.611-18.86-5.922-22.32-12.272-16.798-12.762-10.513-4.261-3.435-4.7230.3810.7020000
WPA (Winst Per Aandeel) -0.92-3.47-0.95-0.92-0.78-0.69-0.7-0.7-0.5-0.71-0.6-0.82-0.77-0.68-0.75-0.64-0.64-0.54-0.47-1.390.511.93-0.61-0.71-0.64-6.88
Verwaterde WPA -0.92-3.47-0.95-0.92-0.78-0.69-0.7-0.7-0.5-0.71-0.6-0.82-0.77-0.68-0.75-0.64-0.64-0.54-0.47-1.390.481.93-0.58-0.68-0.61-6.88
EBITDA -58.935-48.44-56.354-54.364-45.997-40.324-40.125-39.769-36.176-33.716-29.585-28.647-27.401-24.181-26.725-22.534-22.56-18.669-16.331-16.65511.3242.512-13.075-15.461-14.094-6.11
EBITDA ratio 00000-8.3310-160.359-27.159-17.158-19.963-5.742-21.938-12.097-16.599-12.596-10.377-4.181-3.392-4.6260.3910.7450000